Sumner Michael John
Inovio Pharmaceuticals, Inc. · Chief Medical Officer
Sumner Michael John is listed in filings as Chief Medical Officer at Inovio Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 24 public disclosures. Recent filings connect the profile to Inovio Pharmaceuticals, Inc. (INO). The current snapshot covers public activity from Jul 1, 2024 to May 21, 2026. Reported amounts are shown as $3.3K to $884. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||